impact dashboard - september 2018

Similar documents
impact dashboard - august 2018

impact dashboard - june 2018

impact dashboard - may 2018

impact dashboard year-end with 2017 coefficients

Impact Dashboard - August 2014

Impact Dashboard - October 2014

February Health Impact Report 2010

October 2011 Monthly Health Impact Report

Annex 2 A. Regional profile: West Africa

Sexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions

2015 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

Comparative Analyses of Adolescent Nutrition Indicators

Global Fund ARV Fact Sheet 1 st June, 2009

Global Fund Results Fact Sheet Mid-2011

Eligibility List 2018

Family Planning: Succeeding in Meeting Needs To Make a Better World. Amy Tsui April 12, 2011

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

2006 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

2002 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

2007 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

2009 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

2010 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Main global and regional trends

JOINT TB AND HIV PROGRAMMING

Various interventions for controlling sexually transmitted infections have proven effective, including the syndromic

SGCEP SCIE 1121 Environmental Science Spring 2012 Section Steve Thompson:

ANNEX 3: Country progress indicators

The Private Sector: Key to Achieving Family Planning 2020 Goals

Tipping the dependency

THE CARE WE PROMISE FACTS AND FIGURES 2017

IX. IMPROVING MATERNAL HEALTH: THE NEED TO FOCUS ON REACHING THE POOR. Eduard Bos The World Bank

UNAIDS 2013 AIDS by the numbers

To Tie the Knot or Not: A Case for Permanent Family Planning Methods

Global summary of the AIDS epidemic, December 2007

ICM: Trade-offs in the fight against HIV/AIDS

Global Fund Mid-2013 Results

BCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child

Financing malaria control

MATERNAL, NEWBORN, AND CHILD HEALTH

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

What is this document and who is it for?

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

D TA companion & Scorecard. to the UNICEF Gender Action Plan. May 2016

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Maternal Deaths Disproportionately High in Developing Countries

UPDATE UNAIDS 2016 DATE 2016

The Global HIV/AIDS Epidemic, risk factors for transmission. and Global response. Training Course in Sexual and Reproductive Health Research 2014

Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030?

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

U.S. Funding for International Family Planning & Reproductive Health

AIDS in Africa. An Update. Basil Reekie

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

Private Sector Opportunities to Support Family Planning and Access to Reproductive Health Services

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

Supplementary appendix

Donor Support for Contraceptives and Condoms for STI/HIV Prevention

DATA COMPANION & & SCORECARD. to the UNICEF Gender Action Plan. May 2017

Access to Stigma-Free Healthcare Settings for Key Populations: Challenges and Opportunities

מדינת ישראל. Tourist Visa Table

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

Aboubacar Kampo Chief of Health UNICEF Nigeria

UNAIDS Office on AIDS, Security and Humanitarian Response; Initiative on HIV/AIDS and Uniformed Services, with special emphasis on young recruits

Seizures of ATS (excluding ecstasy ), 2010

HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR

1. Consent for Treatment This form must be completed in order to receive healthcare services in the campus clinic.

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

#1 #2 OR Immunity verified by immune titer (please attach report) * No titer needed if proof of two doses of Varicella provided

Human Immunodeficiency Virus

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts

Certificate of Immunization

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division

HIV in Women: A Global View of the HIV Epidemic

Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000)

Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations

HIV and development challenges for Africa Catherine Hankins, Associate Director & Chief Scientific Adviser to UNAIDS

Update on progress of MPP sublicensees

HIV in Women: A Global View of the HIV Epidemic

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i

Comments on this bulletin are welcome. Please to Dr. Mary Agócs

THE FUTURE OF ADULT MORTALITY UNDER THE AIDS THREAT: ESTIMATING AND PROJECTING INCIDENCE; PROJECTING MORTALITY WITH HIV/AIDS *

Update from GAVI Aurelia Nguyen

Global reductions in measles mortality and the risk of measles resurgence

Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa

Lessons learned from the IeDEA West Africa Collaboration

Ending the AIDS Epidemic in Adolescents

Children in Africa. Key statistics on child survival, protection and development

Transcription:

impact dashboard - september 2018 PSI 2015 As of, PSI averted an estimated 17.1 M DALYs, provided 12.5 M CYPs, and reached 18.4 M users globally. Globally PSI has reached at least 18.4 million users across the five health areas in 2018: 7.6 M with malaria tests; 7.6 M with modern contraception; 2.3 M with HIV testing, 737,000 with NCD screening; and 173,000 with toilets. PSI safe abortion work in 18 countries has reached 1.3 million women and achieved an estimated 1.2 million completed abortions in 2018. PSI has reached 7.6 million women with modern contraception and provided 12.5 million CYPs in 2018. Overall, PSI is behind the YTD 2018 program targets for CYPs which should be at 75%: condoms @ 66%, LTMs @ 70%, STMs @ 86%, and PMs @ 110% of the targets. Among the top 15 CYP producers, India LLC, Malawi, and South need to boost their CYP performance the rest of the year to meet the annual targets. Service provision provided ~5 million CYPs in 2018. The CYP ratio for product distribution to service provision is also shifted from 70:30 last year to 60:40 this year. PSI PROGRESS ON HEALTH IMPACT % Change from 2018 Program % 2018 Program Target SP Target % SP Target Time Elapsed DALYs 1,871,629 17,104,714-20% 22,503,745 76% 100,000,000 17% 25% CYPs Provided 1,674,827 12,543,135-16% 17,207,079 73% 75,000,000 17% (9/36 months) Users Reached # 1,599,234 18,431,481-8% 16,608,910 111% 90,000,000 20% # The sum of clients who receive modern contraception, testing for HIV (among high risk), testing for malaria, NCD screening, or toilets from PSI. PSI PROGRESS IN DALYS AVERTED, CYPS PROVIDED, AND USERS REACHED # Target: 25% increase in DALYs averted relative to 2012-2016 DALYs by Region CYPs Provided by Region Southern 40% East 32% West & Central 19% Latin America & Caribbean 1% Asia & Eastern Europe 8% Latin America & Caribbean 6% Southern 16% Asia & Eastern Europe 36% East 28% West & Central 14% Users Reached # by Region Latin America & Caribbean 4% Asia & Eastern Europe 27% Southern 33% East West & Central 9% PSI REGIONAL AND HEALTH AREA PERFORMANCE Region DALYs YTD % of 2018 Program CYPs Provided YTD % of 2018 Program West & Central 169,752 3,182,896-58% 83% 211,666 1,725,484-55% 103% East 831,953 5,408,462-4% 69% 601,904 3,475,288-14% 77% Southern 678,330 6,800,721 6% 82% 218,726 2,050,306 8% 80% Latin America & Caribbean 19,041 243,238 29% 107% 71,887 711,291 47% 101% Asia & Eastern Europe 172,553 1,469,398-6% 65% 570,643 4,580,767-4% 59% TOTAL 1,871,629 17,104,714-20% 76% 1,674,827 12,543,135-16% 73% Health Area DALYs Users Reached # Users Reached # YTD % of 2018 Program Testing for Malaria 360,531 7,622,635 2% 252% Modern Contraception 906,877 7,559,880-21% 73% Testing for HIV 244,196 2,338,392 23% 92% NCD Screening 49,937 737,060 36% 170% Toilets Sold 37,693 173,514-72% 77% TOTAL 1,599,234 18,431,481-8% 111% CYPs Provided Modern Contraception 41% Testing for HIV 13% Users Reached # by Health Area Testing for Malaria 41% NCD Screening 4% Toilets Sold 0.9% IMPACT DASHBOARD - SEPTEMBER 2018 1

COUNTRIES BY YTD 2018 DALYS AVERTED 100% DALYs % of DALYs % DALYs Mali 16,541 2,060,021-20% 2,827,378 73% 2,060,021 12.0% Zimbabwe 234,452 1,703,758 26% 1,998,944 85% 1,703,758 10.0% South 147,585 1,447,080-18% 2,668,799 54% 1,447,080 8.5% Kenya 245,585 1,427,169 28% 1,847,212 77% 1,427,169 8.3% Madagascar 36,531 1,380,119 75% 1,096,683 126% 1,380,119 8.1% South Sudan 146,646 1,177,053-21% 2,286,907 51% 1,177,053 6.9% Uganda 216,471 975,329 17% 1,200,788 81% 975,329 5.7% Malawi 62,941 788,484-12% 948,879 83% 788,484 4.6% Angola 142,065 620,077 0% 785,540 79% 620,077 3.6% Swaziland 51,363 610,802 10% 885,727 69% 610,802 3.6% Tanzania 103,270 600,496-38% 921,192 65% 600,496 3.5% Pakistan 57,949 478,348-24% 398,086 120% 478,348 2.8% Lesotho 3,959 447,344 126% 139,130 322% 447,344 2.6% India LLC 59,017 403,336 36% 1,073,307 38% 403,336 2.4% Nigeria 40,103 393,267-86% 96,981 406% 393,267 2.3% Cameroon 21,472 301,359 31% 423,028 71% 301,359 1.8% Mozambique 45,890 293,280-16% 437,315 67% 293,280 1.7% Zambia 12,498 284,879-62% 271,525 105% 284,879 1.7% Benin 76,368 220,313 14% 285,082 77% 220,313 1.3% Myanmar 20,017 205,202-10% 317,691 65% 205,202 1.2% Ethiopia 31,394 198,413 178% 201,948 98% 198,413 1.2% Cambodia 16,637 153,746 10% 191,608 80% 153,746 0.9% India 9,283 142,871 10% 146,584 97% 142,871 0.8% Haiti 6,373 129,847 37% 107,687 121% 129,847 0.8% Burundi 21,899 111,583 5% 153,525 73% 111,583 0.7% Rwanda 0 104,356-23% 244,226 43% 104,356 0.6% Ghana 4,200 93,468-38% 88,962 105% 93,468 0.5% Senegal 6,940 57,964 91% 63,626 91% 57,964 0.3% Guatemala 6,336 52,597 82% 33,693 156% 52,597 0.3% Niger 3,189 38,625 75% 36,542 106% 38,625 0.2% Nepal 2,862 31,571 31% 40,232 78% 31,571 0.2% Somaliland 3,747 25,579 6% 46,705 55% 25,579 0.1% Viet Nam 4,056 20,867-1% 40,972 51% 20,867 0.1% Laos 2,457 18,537 19% 35,465 52% 18,537 0.1% Paraguay 1,597 15,454-3% 22,628 68% 15,454 0.1% Honduras 1,428 14,728 15% 15,924 92% 14,728 0.1% Botswana 3,401 11,930-30% 20,439 58% 11,930 0.1% Tajikistan 94 11,700-8% 10,399 113% 11,700 0.1% Dominican Republic 1,707 11,037-26% 19,020 58% 11,037 0.1% Cote d'ivoire 513 9,232 375% 11,162 83% 9,232 0.1% Nicaragua 905 8,400-13% 12,449 67% 8,400 0.0% Liberia 426 7,452 54% 13,866 54% 7,452 0.0% El Salvador 322 5,495-6% 8,414 65% 5,495 0.0% Panama 214 4,070 0% 6,012 68% 4,070 0.0% Papua New Guinea 0 2,062-97% 2,270 91% 2,062 0.0% Costa Rica 159 1,610 15% 1,940 83% 1,610 0.0% Namibia 586 1,453-58% 16,305 9% 1,453 0.0% Guinea 0 1,194-99% NA NA 1,194 0.0% Kazakhstan 138 667 81% 277 241% 667 0.0% Kyrgyzstan 42 490-8% 667 74% 490 0.0% PSI GLOBAL 1,871,629 17,104,714-20% 22,503,745 76% 17,104,714 100% PSI South ** 75,073 471,936-31% 1,013,490 47% 471,936 2.8% **included sales / distribution in Botswana, Lesotho, Namibia, South, Swaziland, and Zambia. These sales / distribution are also included in the countries above. - IMPACT DASHBOARD - SEPTEMBER 2018 2

PSI PRODUCTS & SERVICES BY YTD 2018 DALYS AVERTED 100% 0% Products / Services DALYs % of # Distributed Reporting 2018 CYPs Condom 359,073 2,936,132-28% 64% 345,575,353 35 2,879,795 Free Condom 248,279 2,436,895 4% 82% 127,109,789 22 1,059,248 Voluntary Medical Male Circumcision 266,045 2,292,594 6% 81% 349,749 6 Malaria PPT (ACT) 49,751 2,118,448-49% 89% 6,682,320 8 LLIN 203,147 1,780,547-18% 54% 11,048,701 14 IUD Insertion 145,958 1,326,305 3% 91% 542,653 29 2,373,882 Implant Insertion 157,012 1,111,199 16% 131% 532,887 29 1,694,098 Seasonal Malaria Chemoprevention 0 521,220-31% 100% 1,665,225 1 Pneumonia PPT 97,007 446,558 73% 99% 602,467 4 IUD Distribution 110,845 342,812-23% 41% 222,441 21 931,208 Injectable Contraception Dist. 26,547 318,955-56% 102% 4,654,303 22 1,135,909 OCs 27,500 265,290-48% 79% 19,434,413 24 1,295,628 TB DOTS 18,882 211,489 25% 186% 47,323 5 Tubal Ligation 18,958 196,838 32% 97% 50,920 8 596,383 Medical Abortion 11,794 108,832 95% 80% 1,146,246 4 Misoprostol for Safe Abortion 9,341 97,147 306% 74% 4,125,002 14 Injectable Contraception Provided 11,531 90,629 28% 154% 1,222,641 27 287,684 ORS 4,777 78,745 49% 72% 2,678,348 4 Antiretroviral Treatment 9,840 64,715 0% 304% 370,379 10 HIV Testing Services 3,983 55,610-30% 66% 1,922,422 28 Diarrhea Treatment Kit 23,080 46,210-52% 67% 540,089 5 Needle & Syringe 4,027 27,121-27% 59% 3,447,415 2 OCs Provided 3,182 25,652 7% 97% 1,127,368 27 75,158 Safe Water Solution 1,075 24,049-25% 61% 4,661,200 9 Skilled Birth Attendance 2,450 23,169-42% 169% 23,562 2 Female/Woman Condom 534 17,718-11% 30% 1,012,295 9 8,436 Free Female Condom 3,602 15,111-23% 96% 831,141 13 6,926 Referral 1,524 14,874-16% 41% 18,721 17 1,500 Implant Distribution 42,094 14,103-95% 5% 21,915 20 71,795 QAACTs Provided after Confirmatory Diagno 1,762 13,197 430% 1058% 82,804 5 Misoprostol for PAC Provided 940 8,664 84% 97% 52,781 12 Emergency Contraception 581 8,654-62% 53% 2,102,557 12 105,128 Pneumonia PPT Provided 848 7,879-91% 40% 16,381 1 Chlorhexidine 60 7,012-37% 243% 114,753 2 Water Treatment Tablets 661 6,204-25% 57% 28,475,102 11 Toilets Sold 1,505 5,951-71% 85% 36,580 6 Zinc 625 5,615-81% 124% 501,946 2 Manual Vacuum Aspiration for PAC 555 4,915 49% 146% 37,412 13 IPTp2 17 4,765 63% 35% 80,890 2 SDM (Cycle Beads) 680 3,569-87% 241% 5,137 3 7,706 Clean Delivery Kit 309 3,442 2% 71% 27,917 1 Naloxone 0 2,729-10% 1000% 2,000 1 PUR 243 2,421-3% 106% 58,139,854 6 IUS Distribution 11 2,040 128% 20% 1,030 3 3,341 IUS Insertion 166 1,448 4% 217% 651 5 2,081 Vasectomy 99 1,346-80% 36% 501 2 5,772 STI Treatment 177 1,301-24% 256% 19,132 7 Medical Abortion Provided 111 1,049 73% 170% 9,752 4 Diarrhea Treatment Kit Provided 75 581-17% NA 15,087 2 Multivitamin 50 488 9% 52% 1,900,300 2 Fecal Sludge Management 77 451 101% 36% 606 2 0 Vivax Treatment after Confirmatory Diagnosi 57 383 46% 36% 2,323 2 SDM (Cycle Beads) Provided 43 370-94% 41% 463 4 695 Cervical Cancer Treatment 29 289-66% 33% 1,022 8 Manual Vacuum Aspiration for SA 43 254 NA 35% 760 5 STI Kit 26 243-35% 34% 3,555 1 Medical Abortion (Misoprostol) Provided 37 173 NA NA 531 3 PrEP 18 130 89% 11% 3,954 3 Misoprostol for PPH 7 123-99% 66% 19,800 1 Emergency Contraception Provided 8 92 78% 13% 15,279 16 764 ORS Provided 7 62-99% NA 1,636 1 Treatment for Pre-Eclampsia (with MgSO4) 0 39-39% 110% 43 1 Zika Prevention Kit 5 10 580% 114% 714 1 Malaria PPT (Non-ACT) -38-144 -186% -1% -1,053 1 HIV Self-Testing Kit NA NA NA NA 461,910 3 IRS (# of household) NA NA NA NA 0 0 Malaria RDK NA NA NA NA 7,612,722 8 Micronutrient Powder NA NA NA NA 6,754,259 3 Treatment for Severe Acute Malnutrition 0 0-100% 0% 0 0 PSI GLOBAL 1,871,629 17,104,714-20% 76% 12,543,135 IMPACT DASHBOARD - SEPTEMBER 2018 3

YTD 2018 CASES AND DEATHS AVERTED BY PRODUCTS & SERVICES Products / Services DALYs Deaths HIV Cases Maternal Deaths Unintended Pregnancies # Distributed Condom 359,073 2,936,132 57,142 693 412,575 345,575,353 Free Condom 248,279 2,436,895 54,405 376 151,754 127,109,789 Voluntary Medical Male Circumcision 266,045 2,292,594 41,653 349,749 Malaria PPT (ACT) 49,751 2,118,448 24,701 6,682,320 LLIN 203,147 1,780,547 22,424 11,048,701 IUD Insertion 145,958 1,326,305 1,788 830,985 542,653 Implant Insertion 157,012 1,111,199 1,716 583,454 532,887 Seasonal Malaria Chemoprevention 0 521,220 6,047 1,665,225 Pneumonia PPT 97,007 446,558 5,227 602,467 IUD Distribution 110,845 342,812 403 294,221 222,441 Injectable Contraception Dist. 26,547 318,955 541 255,711 4,654,303 OCs 27,500 265,290 472 296,001 19,434,413 TB DOTS 18,882 211,489 3,948 47,323 Tubal Ligation 18,958 196,838 288 243,750 50,920 Medical Abortion 11,794 108,832 1,886 1,146,246 Misoprostol for Safe Abortion 9,341 97,147 1,722 4,125,002 Injectable Contraception Provided 11,531 90,629 125 72,028 1,222,641 ORS 4,777 78,745 878 2,678,348 Antiretroviral Treatment 9,840 64,715 1,055 370,379 HIV Testing Services 3,983 55,610 1,385 1,922,422 Diarrhea Treatment Kit 23,080 46,210 530 540,089 Needle & Syringe 4,027 27,121 3,447,415 OCs Provided 3,182 25,652 35 19,079 1,127,368 Safe Water Solution 1,075 24,049 451 4,661,200 Skilled Birth Attendance 2,450 23,169 164 38 23,562 Female/Woman Condom 534 17,718 331 3 930 1,012,295 Free Female Condom 3,602 15,111 295 2 763 831,141 Referral 1,524 14,874 1,333 765 0.3 514 18,721 Implant Distribution 42,094 14,103-55 22,242 21,915 QAACTs Provided after Confirmatory Diagno 1,762 13,197 152 82,804 Misoprostol for PAC Provided 940 8,664 151 52,781 Emergency Contraception 581 8,654 12 9,462 2,102,557 Pneumonia PPT Provided 848 7,879 92 16,381 Chlorhexidine 60 7,012 81 114,753 Water Treatment Tablets 661 6,204 105 28,475,102 Toilets Sold 1,505 5,951 200 36,580 Zinc 625 5,615 64 501,946 Manual Vacuum Aspiration for PAC 555 4,915 86 37,412 IPTp2 17 4,765 56 80,890 SDM (Cycle Beads) 680 3,569 6 2,747 5,137 Clean Delivery Kit 309 3,442 44 27,917 Naloxone 0 2,729 48 2,000 PUR 243 2,421 46 58,139,854 IUS Distribution 11 2,040 2 1,082 1,030 IUS Insertion 166 1,448 2 748 651 Vasectomy 99 1,346 1 2,520 501 STI Treatment 177 1,301 25 19,132 Medical Abortion Provided 111 1,049 18 9,752 Diarrhea Treatment Kit Provided 75 581 7 15,087 Multivitamin 50 488 6 1,900,300 Fecal Sludge Management 77 451 13 606 Vivax Treatment after Confirmatory Diagnosi 57 383 4 2,323 SDM (Cycle Beads) Provided 43 370 1 275 463 Cervical Cancer Treatment 29 289 1,022 Manual Vacuum Aspiration for SA 43 254 4 760 STI Kit 26 243 5 3,555 Medical Abortion (Misoprostol) Provided 37 173 3 531 PrEP 18 130 3 3,954 Misoprostol for PPH 7 123 2 19,800 Emergency Contraception Provided 8 92 0.1 76 15,279 ORS Provided 7 62 1 1,636 Treatment for Pre-Eclampsia (with MgSO4) 0 39 1 43 Zika Prevention Kit 5 10 714 Malaria PPT (Non-ACT) -38-144 -2-1,053 HIV Self-Testing Kit NA NA 461,910 IRS (# of household) NA NA 0 Malaria RDK NA NA 7,612,722 Micronutrient Powder NA NA 6,754,259 Treatment for Severe Acute Malnutrition 0 0 0 PSI GLOBAL 1,871,629 17,104,714 70,522 157,034 6,448 3,200,915 IMPACT DASHBOARD - SEPTEMBER 2018 4

COUNTRIES BY YTD 2018 CYPS PROVIDED 100% 2018 CYPs CYPs % of 2018 CYPs FP Method Mix** CYPs Provided % of CYPs Provided Pakistan 218,157 1,714,369-23% 93% 1,714,369 13.7% Uganda 278,478 1,230,046 18% 83% 1,230,046 9.8% India LLC 211,839 1,162,424 23% 31% 1,162,424 9.3% Madagascar 92,267 804,047 17% 92% 804,047 6.4% Kenya 173,485 752,231-9% 75% 752,231 6.0% Tanzania 60,338 694,472-44% 75% 694,472 5.5% Cambodia 61,056 561,589 7% 77% 561,589 4.5% India 32,072 507,465 41% 97% 507,465 4.0% Malawi 43,872 505,205-32% 68% 505,205 4.0% Myanmar 34,806 437,637-13% 75% 437,637 3.5% South 28,028 369,766-37% 51% 369,766 2.9% Guatemala 42,645 363,857 109% 184% 363,857 2.9% Cameroon 24,135 355,101 35% 75% 355,101 2.8% Nigeria 37,636 337,139-80% NA 337,139 2.7% Ghana 14,978 336,914-37% 109% 336,914 2.7% Benin 101,723 310,708 9% 69% 310,708 2.5% Mali 17,738 235,070 58% 81% 235,070 1.9% Mozambique 32,831 226,044 16% 76% 226,044 1.8% Ethiopia 26,875 170,856 201% 101% 170,856 1.4% Zambia 18,459 163,768 105% 150% 163,768 1.3% Zimbabwe 21,510 144,795 1% 65% 144,795 1.2% Lesotho 953 119,030 131% 567% 119,030 0.9% Swaziland 9,586 112,309 15% 70% 112,309 0.9% Angola 12,758 102,720 169% 72% 102,720 0.8% Nepal 518 99,500 9% 78% 99,500 0.8% Laos 11,765 88,404 15% 50% 88,404 0.7% Senegal 10,492 78,580 95% 89% 78,580 0.6% Rwanda 0 69,655-20% 47% 69,655 0.6% Haiti 136 67,574 396% 68% 67,574 0.5% Paraguay 6,810 65,645 3% 71% 65,645 0.5% Nicaragua 5,829 53,912-5% 77% 53,912 0.4% Dominican Republic 8,319 53,078-28% 57% 53,078 0.4% Burundi 18,555 50,281 37% 73% 50,281 0.4% El Salvador 3,126 46,012-4% 61% 46,012 0.4% Niger 3,733 44,915 85% 108% 44,915 0.4% Honduras 2,863 30,046 17% 82% 30,046 0.2% Panama 1,000 19,430 0% 67% 19,430 0.2% Cote d'ivoire 656 13,946 317% 103% 13,946 0.1% Costa Rica 1,160 11,737 15% 83% 11,737 0.1% Liberia 574 10,231 60% 53% 10,231 0.1% Botswana 1,987 6,971-30% 58% 6,971 0.1% Viet Nam 354 4,245 154% 126% 4,245 0.0% Tajikistan 75 3,800 99% 285% 3,800 0.0% Guinea 0 2,879-98% NA 2,879 0.0% Somaliland 301 2,543 126% 79% 2,543 0.0% Namibia 346 857-58% 9% 857 0.0% Papua New Guinea 0 520-90% 9% 520 0.0% Kazakhstan 0 455 446% 227% 455 0.0% Kyrgyzstan 0 360 NA 31% 360 0.0% South Sudan 0 0 NA NA 0 0.0% PSI GLOBAL 1,674,827 12,543,135-16% 73% 12,543,135 ** # of long-term methods including implants, IUDs and male/female sterilization; # of short-term methods including male condom, female condom, cycle beads, EC, injectables and OC PSI South ** 30,404 186,046-30% 48% 186,046 1.5% ***included sales / distribution in Botswana, Lesotho, Namibia, South, Swaziland, and Zambia. These sales / distribution are also included in the countries above. IMPACT DASHBOARD - SEPTEMBER 2018 5

COUNTRIES BY YTD 2018 USERS REACHED # 100% Modern Contraception Testing for HIV Users Reached # % of 2018 Users Reached Program Testing for NCD Screening Toilets TOTAL Malaria Madagascar 641,211 165,899 3,456,899 692 4,264,701 459% South Sudan 2,566,213 2,566,213 204% Myanmar 386,021 35,895 958,128 155,265 1,535,309 89% Pakistan 1,133,839 1,133,839 88% India LLC 810,033 810,033 36% Kenya 562,391 145,368 23,381 731,140 78% Cambodia 383,812 320,742 704,554 90% Nigeria 77,384 609,489 686,873 NA South 332,789 212,904 545,693 62% Malawi 265,133 228,916 15,503 509,552 139% Uganda 391,958 53,222 445,180 93% Ethiopia 153,770 213,600 15,051 382,422 94% Viet Nam 1,540 6,054 24,145 316,018 11,605 359,362 192% Zambia 96,231 248,220 344,451 62% Haiti 57,242 115,573 165,242 26 338,083 81% Ghana 303,233 425 303,658 109% Tanzania 301,465 39 301,504 82% Zimbabwe 119,282 33,185 124,288 276,755 128% Lesotho 107,425 126,425 2,650 236,500 44% India 73,329 136,814 210,143 87% Cameroon 193,955 8,244 202,199 69% Guatemala 193,418 1,959 195,377 155% Benin 112,165 40,171 33,436 9,575 195,347 84% Mozambique 141,152 141,152 72% Angola 44,054 89,910 133,964 47% Swaziland 100,931 29,490 2,759 133,180 50% Dominican Republic 47,770 31,033 78,803 64% Laos 43,269 4,058 29,090 76,417 68% Mali 65,089 9,686 74,775 82% Senegal 70,250 314 70,564 77% Rwanda 62,689 62,689 47% Burundi 40,996 18,437 59,433 77% Paraguay 59,080 59,080 71% Niger 22,517 12,745 35,262 153% Nicaragua 29,271 411 29,682 62% Honduras 26,662 2,458 29,120 89% El Salvador 24,233 2,231 95 26,559 65% Nepal 22,946 22,946 83% Cote d'ivoire 7,707 12,881 44 20,632 66% Kyrgyzstan 324 18,951 19,275 113% Panama 17,487 1,123 18,610 66% Tajikistan 3,420 13,033 16,453 108% Liberia 9,207 5,773 14,980 58% Costa Rica 10,563 10,563 83% Botswana 6,274 6,274 58% Papua New Guinea 468 4,022 4,490 88% Guinea 2,591 2,591 NA Kazakhstan 409 1,796 2,205 81% Somaliland 2,122 2,122 100% Namibia 771 771 3% PSI GLOBAL 7,559,880 2,338,392 7,622,635 737,060 173,514 18,431,481 111% # The sum of clients who receive modern contraception, testing for HIV (among high risk), testing for malaria, NCD screening, and toilets from PSI. PSI South ** 167,442 167,442 48% ***included sales / distribution in Botswana, Lesotho, Namibia, South, Swaziland, and Zambia. These sales / distribution are also included in the countries above. IMPACT DASHBOARD - SEPTEMBER 2018 6

PSI PROGRESS ON SAFE ABORTION, Product Distribution and Service Provision # Distributed / Safe Abortion Users Completed DALYs # Service Reached Abortions :: Product Distribution 1,248,184 1,164,119 205,979 Medical Abortion 1,146,246 1,031,621 980,040 108,832 1,429,599 80% Misoprostol for Safe Abortion 4,125,002 216,563 184,078 97,147 5,238,648 79% :: Service Provision 101,236 91,068 15,054 Manual Vacuum Aspiration for PAC 37,412 37,412 29,930 4,915 15,546 241% Manual Vacuum Aspiration for SA 760 760 752 254 1,854 41% Medical Abortion (Misoprostol) Provided 531 531 451 173 Medical Abortion Provided 9,752 9,752 9,264 1,049 4,254 229% Misoprostol for PAC Provided 52,781 52,781 50,670 8,664 19,485 271% Total 1,349,420 1,255,186 221,034 PSI PROGRESS ON SERVICE PROVISION AND REFERRAL, :: CYPs and DALYs from FAMILY PLANNING SERVICES AND REFERRALS by DELIVERY CHANNEL Service Provision and Referral Franchise Facilities PSI Direct Service Provision Service Delivery Partner Emergency Contraception 591 107 66.0 1 765 92 Implant Insertion 474,816 668,992 550,290 263 1,694,361 1,111,248 Injectables 58,214 43,985 185,484 46 287,730 90,638 IUD-IUS Insertion 1,283,425 290,721 801,817 1,168 2,377,131 1,327,970 Oral Contraceptives 8,111 16,967 50,079 11 75,169 25,654 SDM (Cycle Beads) 639 32 24 695 370 Tubal Ligation 17,450 124,310 454,623 10 596,393 196,841 Vasectomy 1,900 3,872 5,772 1,346 Total 1,845,146 1,145,114 2,046,256 1,500 5,038,016 2,754,161 :: SELECTED SERVICES AND REFERRALS PROVIDED by DELIVERY CHANNEL Referral and Service Provision Franchise Facilities CYPs by Delivery Channel (excluding condoms) # Service by Delivery Channel PSI Direct Service Provision Service Delivery Partner Antiretroviral Treatment 45,200 105,969 219,210 14,001 384,380 73,321 HIV Testing Services 266,890 447,086 1,208,446 251 1,922,673 55,622 PrEP 1,540 2,406 8 20 3,974 131 Voluntary Medical Male Circumcision 51,113 96,353 202,283 139 349,888 2,293,133 Sexually Transmitted Infection Treatment 13,864 1,444 3,824 298 19,430 1,315 TB Treatment 9,663 94 37,566 2,036 49,359 216,908 Fever Cases Tested with RDTs 144,879 1,072 625,234 771,185 0 Positive RDTs 15,549 10 15,255 30,814 0 QAACTs Provided after confirmatory diagnosis 80,072 6 2,726 82,804 13,197 Vivax Treatment after confirmatory diagnosis 514 1 1,808 2,323 383 Counseling & Tx for Moderate Acute MalnutritionCU5 0 Treatment for Severe Acute Malnutrition 0 CU5 Treated with DTK after diarrhea dignosis 15,087 15,087 581 CU5 Treated with ORS after diarrhea dignosis 1,636 1,636 62 CU5 Treated with Zinc after diarrhea dignosis 0 CU5 Treated with antibiotics after pneumonia dignosis 16,381 16,381 7,879 Facility Delivery/Skilled Birth Attendance 16,384 80 7,098 23,562 23,169 IPTp2 2,758 78,132 80,890 4,765 Treatment for Pre-Eclampsia (with MgSO4) 43 43 39 Safe Abortion & PAC Services 34,041 67,195 101,236 15,054 Cervical Cancer Screening 85,669 41,796 23,827 151,292 Cervical Cancer Treatment 486 362 76 98 1,022 289 Hypertension Screening 258,045 133,764 188,510 580,319 Hypertension Controlled Condition 68,400 42 68,442 Type 2 Diabetes Screening 1,073 4,226 150 5,449 Type 2 Diabetes Controlled Condition 3 2 5 Referrals Referrals 2018 #Distributed / #Service Target CYPs Provided # Service % 2018 Target Achieved DALYs DALYs Total 1,129,290 834,713 2,681,348 16,843 4,662,194 2,705,850 IMPACT DASHBOARD - SEPTEMBER 2018 7